Daniel R. Saban, PhD is the recipient of the 2024 Cogan Award, presented by the Association for Research in Vision and Ophthalmology (ARVO).

Asiya Gusa, PhD, assistant professor of molecular genetics and microbiology, has been named a Canadian Institute for Advanced Research (CIFAR) Azrieli Global Schol

Medical students Lily Guo and Linda Li each had different experiences before coming to Duke, but an affinity group for Asian American students gave them both a sense of belonging that they said the

Carlene Moore, PhD, an assistant professor in neurology, is opening up new avenues of research in the quest to develop novel therapies for migraines and other painful neurological diseases.

Autologous conditioned serum (ACS) -- a biologic therapy that famous athletes swear by to treat arthritis and sports injuries -- also shows benefit for the kind of neurological pain caused by chemotherapy or diabetes.

A Conversation with Svati Shah, MD, about One DukeGEN, an initiative that uses genetics and advanced technologies to quickly translate scientific discovery into better clinical treatments.

The Michelle P. Winn Awards honor individuals and teams who exemplified inclusive excellence over the past year. Each year, Winn Awards are given to one staff member, faculty member, student, and team from across the more than 10,000 members of the School of Medicine. 

The COVID-19 pandemic forced medical residency programs to change their approach to interviewing, switching from traditional in-person meetings to virtual conversations via computer video. &nb

Duke University School of Medicine is proud to acknowledge the faculty members who were selected as recipients of this year’s School of Medicine faculty awards.

A new study from researchers in the Duke University School of Medicine suggests a potential targeted therapy for otherwise untreatable forms of advanced prostate cancer.